Context: Although the skeleton is a well-known thyroid hormone target organ, very little data are available on the association of thyroid function with bone outcomes during childhood.
T hyroid hormone (TH) regulates metabolism in practically all tissues of the human body (1) and plays an important role during childhood by regulating growth (2) , neuropsychological development (3, 4) , and the cardiovascular system (5) . Bone is a well-known target organ of TH, also during childhood. This is demonstrated by studies showing that children with congenital hypothyroidism have short stature, delayed skeletal development and impaired bone maturation (2) . Furthermore, in this specific subgroup, TH replacement therapy can induce "catch-up" growth and acceleration of skeletal maturation (6) , leading to achievement of normal height and normal bone mass if initiated from the neonatal period (7, 8) . On the other hand, juvenile hyperthyroidism is associated with accelerated skeletal development and rapid growth (9, 10) . In adults, hyperthyroidism increases the risk of osteoporosis, which is reflected by low bone mineral density (BMD) and a higher risk of fracture (11, 12) .
In line with in vitro and animal studies, clinical studies suggest that even high-normal TH concentrations and/or low-normal TSH concentrations are associated with a higher bone turnover state, which may lead to a net increase in bone resorption, a decrease in BMD and a higher risk of fractures (2, 13, 14) . This would mean that higher TH availability would lead to a decrease in bone mass. However, it remains unknown if the effects of TH concentrations during early bone development are similar. Despite the well-known regulating role of TH on the skeleton in experimental settings and the numerous clinical studies performed in human adults, clinical studies that aim to study the effects of TH on bone development during early childhood are sparse. In addition, some studies suggest that also TSH might play a direct role in the skeletal development and maintenance by inhibiting osteoclastogenesis and function (2, 15) and possibly by exerting effects on osteoblasts as well (2, 15) . Nevertheless, the association of TSH with markers of bone status during childhood are unclear.
The aim of this study was to investigate the association of TSH and free T4 (FT4) with BMD and bone mineral content (BMC) during childhood.
Subjects and Methods

Study design
This study was embedded in Generation R, a prospective, multiethnic, population-based cohort from early fetal life onwards, in Rotterdam, Netherlands (16) . The study was designed to identify early environmental and genetic determinants of growth, development, and health during fetal life, childhood, and young adulthood (16) . Eligible participants were children born in the Rotterdam metropolitan area between 2002 and 2006 of which nearly 10,000 were included in the Generation R study. A total of 6690 children subsequently visited the research center at roughly 6 years of age, of which 4306 were included for the current study [main loss to follow-up due to a lack of consent or an unsuccessful venipuncture (16) ]. Participants who used medication that could interfere with thyroid function (mainly levothyroxine or growth hormone treatment) or who suffered from endocrine disease, chronic illness, or cancer were excluded.
Thyroid measurements
TSH and FT4 concentrations were measured in serum samples obtained at a median age of 6 (95% range, 5.6 to 7.9 years) or in cord blood samples that were obtained directly after birth (median gestational age at birth, 40.1 weeks; 95% range, 35.8 to 42.3 weeks). Plain tubes were centrifuged and serum was stored at 280°C. TSH and FT4 concentrations were determined in cord blood samples using chemiluminescence assays (Vitros ECI; Ortho Clinical Diagnostics, Rochester, NY). The intra-assay and interassay variation coefficients were ,4.1% for TSH at a range of 3.97 to 22.7 mU/L and ,5.4% for FT4 at range of 14.3 to 25.0 pmol/L. At 6 years of age, TSH and FT4 were measured using an electrochemiluminescence immunoassay on the Cobas e601 immunoanalyzer (Roche Diagnostics Mannheim, Germany). The intra-assay and interassay coefficients of variation were 1.1% to 3.0% for TSH at a range of 0.04 to 0.4 mU/L and 1.6% to 5.0% for FT4 at a range of 1.6 to 24.1 pmol/L.
Bone density measurements
At the median age of 6 and median age of 10 years (95% range, 9.0 to 10.9 years), BMD was measured using a dualenergy X-ray absorptiometry (DXA) scan (Idxa; General Electrics -Lunar, 2008). Trained research assistants obtained DXA scans by using the same device and software (enCORE, version 13; GE Health Care) following standard manufacturer protocols. Daily quality assurance was performed by using a spine phantom. More details regarding scanning procedures were previously described (17) . BMD measured by DXA was expressed as BMC (in g) per projected bone area (in cm 2 ). As recommended by the International Society for Clinical Densitometry, BMC and BMD values of the total body without the head was used, so that bone density of the skeleton is best represented for this specific population (18) . Due to the fact that DXA bone measurements during childhood can overestimate the true total body BMD when measuring larger bones, whereas BMD in smaller bones can be underestimated, all models were adjusted for height and soft tissue mass (19) and BMC values were standardized for total bone area (19) . In addition, data on childhood fractures were obtained through questionnaires during follow-up, and were available in a subset of n = 2397 children.
Covariates
Weight and height were measured without shoes and heavy clothing. Total body DXA scans were used to assess body composition (body lean and fat mass); subsequently soft tissue mass was determined by adding lean mass to fat mass. Information on ethnicity was obtained through questionnaires and was defined by the country of origin of the parents, according to the classification of Statistics Netherlands (16) . A participant was considered to have non-Dutch ethnic origin if one of her parents was born abroad. If both parents were born abroad, the country of birth of the participant's mother determined the ethnic background (16) . A participant was considered European if he or she was Dutch or from another European country. Data on educational level of the mother were used as a proxy for socioeconomic status and were obtained through questionnaires. 25-hydroxyvitamin D [25(OH)D] concentrations were available from blood samples drawn at median age 6, using procedures described earlier (20) . Data about sex, birth weight, and gestational age at birth were obtained from medical records and hospital registries.
Statistical analyses
The association of TSH and FT4 with BMD and BMC was examined using multiple linear regression models. We used restricted cubic splines utilizing three knots to account for possible nonlinearity. Multivariable associations were graphically depicted by plots, and standardized b estimates with 95% CIs for the effect estimates are provided. Cox regression models were used to examine the risk of fractures with thyroid function and were graphically depicted by plots and hazard ratios with 95% CIs are provided. All model covariates were selected based on biological plausibility, a 10% change in the effect estimate, or residual variability of the model. All models were adjusted for age, sex, soft tissue mass, height, vitamin D levels adjusted for season, ethnicity, and educational level of the mother. Cord blood models were additionally adjusted for birth weight. As in childhood already substantial variation is present in bone density depending on the ethnic origin (21, 22) , the associations were additionally examined in a subgroup of European participants. Multiple imputation according to Markov Chain Monte Carlo method was used to cope with the missing values of covariates (23) . The missing data were missing at random and were: 16.6% for educational level of the mother at child's age 6; 9.2% for education level of the mother at enrolment during pregnancy; 5.5% for vitamin D; 2.5% for ethnicity; 2.1% for birth weight; 2.0% for child's sex; 1.6% for gestational age at birth; and ,1% for other covariates. Data on thyroid function and bone density measurements were not imputed and were used as predictor variables only. Five imputed data sets were created and pooled for analysis. There were no statistically significant differences between the imputed and the original data sets. There was no interaction of vitamin D with TSH or FT4 at any age. All analyses were performed using Statistical Package of Social Sciences version 21 for Windows (SPSS, Inc., Chicago, IL) and R statistical software version 3.3.3 ('lm.beta', 'rms' and 'foreign' package).
Results
After exclusions, the final study population comprised 4204 children (Fig. 1) , descriptives of which are shown in Supplemental Table 1 . Of all participants, data on cord blood TSH and FT4 were available for 83% (n = 3471), a second DXA scan measurement at median age 10 years was available for 79% (n = 3404), and the majority of the study population (n = 2675; 62%) were of European origin (Supplemental Table 2 ).
Thyroid function at 6 years of age and bone density in the total population
There was an inverse association of TSH with BMD (b 20.028 6 0.011, P = 0.009) measured at the age of 6 years ( Fig. 2) and follow-up measurements of BMD (b 20.027 6 0.011, P = 0.014) at the age of 10 years ( https://academic.oup.com/jcemmeasured at the age of 10 years ( Fig. 3 ; Supplemental Table 3 ). The association of TSH with BMD at 10 years of age and FT4 with BMD and BMC at 10 years of age attenuated considerably when the models were adjusted for bone density at 6 years (P = 0.18, P = 0.93, and P = 0.86, respectively; Supplemental Table 3) .
Thyroid function at 6 years of age and bone density in the subgroup of European participants Considerable ethnic differences in bone density are already present in childhood (21) and therefore we performed a sensitivity analysis studying the above associations in a subgroup of participants of European ethnicity. As is shown in Supplemental Table 3 , there was no association of TSH with BMD and BMC in this homogeneous subset, whereas the associations of FT4 with BMD and BMC at 6 and at 10 years of age did not meaningfully differ from the association in the whole population (Figs. 4 and 5) .
Cord blood thyroid function and bone density
There was an inverse association of cord blood FT4 with BMD at the age of 6 years in the total population, but no other consistent associations of cord blood FT4 or TSH with BMD or BMC could be identified (Supplemental Figs. 1-4) .
Fracture risk
We subsequently investigated if the association of thyroid function with BMD and BMC would also translate into a difference in the risk of fractures. There was no association of TSH or FT4 at any age with fracture risk in both the total study population and in Figure 2 . The association of thyroid function at 6 y with the bone density at 6 y in the total study population. Plots show the linear regression models of TSH and FT4 at age 6 with the BMD and BMC standardized for bone area at age 6, as predicted mean with 95% CI. Analyses were adjusted for age at 6, sex, soft tissue mass, height at 10, vitamin D adjusted for season, ethnicity, and educational level of the mother at age 6.
European participants (Supplemental Figs. 5 and 6; Supplemental Table 4 ).
Discussion
In this large, prospective, population-based study, we demonstrate that a higher FT4 concentration is consistently associated with a lower BMD and BMC during childhood. There was a cross-sectional association at the age of 6 years, as well as a prospective association of FT4 when BMD and BMC were measured at the age of 10 years. The association of FT4 with BMD and BMC remained unchanged when analyzed in an ethnic homogenous group. Although there was an inverse association of TSH with BMD cross-sectionally at the age of 6 years and with follow-up measurements of BMD at the age of 10 years, this association did not extend to BMC measurements and was also not present in a genetically homogenous subgroup. There were no consistent associations of cord blood TSH or FT4 with BMD and BMC. Moreover, there was no indication that thyroid function influences the risk of fracture during childhood.
Population studies in both euthyroid and hyperthyroid adults show that higher TH concentrations and/or lower TSH concentrations are associated with lower BMD (2, 13), but these findings are not directly applicable to a healthy pediatric population. This study investigates the association of thyroid function with bone density in healthy children. Optimizing peak bone mass acquisition in children and adolescents is considered as an important strategy to prevent osteoporosis in later life (24) . Future studies should investigate the impact of early-life thyroid function on clinically relevant outcomes in late adulthood, such as osteoporosis. The association of thyroid function at 6 y with the bone density at 10 y in the total study population. Plots show the linear regression models of TSH and FT4 at age 6 with the BMD and BMC standardized for bone area at age 10, as predicted mean with 95% CI. Analyses were adjusted for age at 10, sex, soft tissue mass, height at 10, vitamin D adjusted for season, ethnicity, and educational level of the mother at age 6.
In the current study, we identified a consistent, inverse association of FT4 with BMD and BMC during early childhood. This suggests that higher TH concentrations, even within the reference range, might lead to lower bone density during childhood. These results are in line with data from experimental studies, which show that TH stimulates osteoblast proliferation, bone matrix synthesis, and mineralization (2, 13, 25) while it also stimulates osteoclast activity and bone resorption directly, or indirectly via osteoblasts or other pathways (2, 13, 25) . Our results suggest that during childhood, TH may play an important role on bone remodeling and add to our understanding of the physiology of bone mass accrual. This knowledge, in combination with data from future studies, could possibly help to identify a subset of children with early life risk factors for adult bone disease that may benefit from more thorough follow-up.
In both the total population as well as the genetically homogeneous subset of children with European ethnicity only, the extent of the association of FT4 with BMC was larger than for BMD. On one hand, this could implicate that TH during bone development has more specific effects on bone mineralization than on linear growth. Alternatively, this difference could at least partly be due to measurement error. DXA bone measurements during childhood can overestimate the true total body BMD when measuring larger bones, whereas BMD in smaller bones can be underestimated (19) . However, it is important to note that for both BMD and BMC, the effect estimates are in a similar direction, which is in line with the strong correlation between BMD and BMC.
A recent study indicates that TH transporters and deiodinases have age-dependent effects on bone mass, mineralization, and postnatal endochondral ossification Figure 4 . The association of thyroid function at 6 y with the bone density at 6 y in the European population. Plots show the linear regression models of TSH and FT4 at age 6 with the BMD and BMC standardized for bone area at age 6, as predicted mean with 95% CI. Analyses were adjusted for age at 6, sex, soft tissue mass, height at 6, vitamin D adjusted for season, and educational level of the mother at age 6.
(26). Our results showed that the inverse association of FT4 with bone density at the age of 10 is driven by the effects of FT4 earlier in childhood. Although bone density measurements have been shown to track over time (27) , the results from the current study could indicate that the effects of TH on bone physiology are more prominent during earlier stages of bone development. Further studies are needed to investigate the potential age-dependent effects of TH availability as well as local TH receptors and deiodinases on bone physiology.
Experimental studies have led to the controversial hypothesis that TSH might directly exert effects on bone by inhibiting osteoclastogenesis and function (2, 15) and possibly by exerting effects on osteoblasts as well (2, 15, 28) . Although some studies in adults suggest that a high TSH concentration might protect against bone loss (29-31), the results of some studies including the current study seem to suggest that the FT4 concentration is a better predictor of TH effects on bone turnover than TSH (31). In our cross-sectional as well as our prospective analyses, we did not detect a consistent association of TSH with bone density. Moreover, it was recently shown that during childhood, the association of TSH with FT4 is not similar to adulthood and that only for high FT4 concentrations there is an inverse relationship with FT4, indicating that interindividual differences in TSH and FT4 in childhood more reflect set point differences rather than responses to pathophysiology or autoimmunity (32) . The statistically significant cross-sectional association of TSH with bone density in the total population might therefore be subject to residual or unmeasured confounding. Apart from the ethnicity-related differences in bone density (21, 33, 34) , TSH concentrations are also known to differ considerably according to ethnic Figure 5 . The association of thyroid function at 6 y with the bone density at 10 y in the European population. Plots show the linear regression models of TSH and FT4 at age 6 with the BMD and BMC standardized for bone area at age 10, as predicted mean with 95% CI. Analyses were adjusted for age at 10, sex, soft tissue mass, height at 10, vitamin D adjusted for season, and educational level of the mother at age 6. doi: 10.1210/jc.2018-00294 https://academic.oup.com/jcembackground and common polymorphisms (32, 35) . However, the findings of our study regarding FT4 are unlikely to be explained by confounding due to ethnicity, as neither correction for ethnic background nor reanalysis in a homogenous population did not influence the results. Further research is needed to examine the possible ethnic and/or genetic differences in the association of TSH with bone density.
Fractures are the most relevant consequences of a lower bone density. In this study, although we demonstrated that a higher FT4 was associated with a lower BMD and BMC, thyroid function was not associated with the risk of fractures during childhood. Although we lacked optimal statistical power due to the fact that fracture data were not available for the total study population, the effect estimates of these analyses were very small. The lack of association of thyroid function with fractures despite the effects on BMD and BMC might be explained by the fact that the differences in BMD and BMC were relatively small and also because in otherwise healthy children, other risk factors such as exposure to injuries are far more important than BMD compared with middle-aged and elderly adults (36) . Furthermore, also the age of the studied children may play an important role. Puberty is an important time for bone acquisition toward the attainment of peak bone mass by the end of skeletal development (37) . Subsequently, peak bone development is an important determinant of osteoporosis risk and osteoporotic fracture risk. Therefore, future follow-up studies are needed to truly assess the relevance of small thyroid function related BMD and BMC differences during childhood and fracture risk.
For the current study, we were able to investigate the association of childhood thyroid function with multiple bone density measurements in a large prospective, population-based setting while using detailed information to adjust for potential confounders. The main limitation of this study is that only one thyroid function measurement during childhood was available, which limits generalization of the results to older ages in childhood and does not take into account time-dependent variations. Moreover, the observational design of this study does not allow for inference of causality and does not preclude the existence of residual confounding even though we were able to adjust for a large number of covariates.
In conclusion, this study provides insights into the effects of thyroid function on bone density during childhood. We show that a higher FT4 concentration is associated with a lower BMD and a lower BMC during childhood. Further studies are needed to investigate whether these associations persist later in childhood and adulthood and to investigate to what extent these associations are determined genetically. Our results suggest that early childhood thyroid function could be a determinant of the quality of bone mineral accrual throughout childhood and bone quality or disease later during adult life.
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